AEGiS-IFRC: HIV TB Global Leaders Forum: IFRC Statement for the HIV TB Global Leaders' Forum held at the United Nations in New York IFRCImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to IFRC main menu
DonateNow


HIV TB Global Leaders Forum: IFRC Statement for the HIV TB Global Leaders' Forum held at the United Nations in New York

International Federation of Red Cross and Red Crescent Societies - June 9, 2008


The International Federation of Red Cross and Red Crescent Societies is committed to the systematic integration of tuberculosis control in Red Cross and Red Crescent HIV programmes at community level, particularly in countries where co-infection has become a public health emergency.

Red Cross and Red Crescent community-based programmes have proven effective in reaching and caring for both people living with HIV and for tuberculosis patients.

There are many similarities in the care they provide. In both cases, our volunteers and staff ensure patients take their medication correctly, provide them with food when needed, offer social and psychological support, and also play a key role in addressing misconceptions and discrimination associated with HIV and TB.

Integrating the programmes is therefore a logical step and a cost-effective measure.

An example is our work in Kazakhstan, where the Red Crescent is providing a range of support a well as specialist medical, legal and psychosocial advice to help people living with TB/HIV cope with the difficult treatment process.

Currently, over 12,000 volunteers worldwide are supporting over 50,000 clients affected by TB, including over 10,000 people also living with HIV. Their activities complement the work of formal health systems by delivering care and support "beyond the clinic door", giving the poor and the marginalized essential access to health services, often in rural areas.

To improve TB/HIV control efforts, we must focus more resources at a community level.

By working with the people affected by TB/HIV to identify and meet their needs, rather than by imposing solutions upon them, we can also make the response to TB/HIV a truly inclusive one, and one that starts at the frontline.

A key element of our work is focused on partnerships. Our 186 member National Red Cross and Red Crescent Societies, as auxiliaries to the public authorities in the humanitarian field, have much to offer partners from all sectors worldwide.

It is our hope that today's important debate will strengthen partnership cooperation towards our common objectives.

This should involve proactive initiatives at the country level including Ministries of Health, but the contribution of the private sector is also vital.

I will give one example of such a wide partnership arrangement today, hoping that it will be seen by governments and other stakeholders as a valuable way of proceeding.

Our community-based work in TB and TB HIV co-infection needs the support of donors prepared to take a long-term perspective.

In this context, we very much appreciate the value of the partnership between the British Red Cross and AstraZeneca - a leading international pharmaceutical company.

AstraZeneca's funding has, since 2002, helped thousands of people living with TB to successfully complete their treatment and provided education to over 750,000 more people living at risk. The company is now supporting our work in TB HIV co-infection in countries such as Lesotho, South Africa and Kazakhstan.

Red Cross Red Crescent Societies are supporting humanitarian needs at the community level in Central Asia and sub-Saharan Africa, complementing the work done by governments and other actors.

We also encourage the development of national strategies to address the TB HIV crisis in our role as auxiliary to government.

In our experience, this form of partnering is vital to achieve our joint objectives.


080609
IF080604


Copyright © 2008 - International Federation of Red Cross and Red Crescent Societies. Reproduction of this article (other than one copy for personal reference) must be cleared through the IFRC Contact.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .